Correlation Between Kancera AB and BioGaia AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kancera AB and BioGaia AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kancera AB and BioGaia AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kancera AB and BioGaia AB, you can compare the effects of market volatilities on Kancera AB and BioGaia AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kancera AB with a short position of BioGaia AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kancera AB and BioGaia AB.

Diversification Opportunities for Kancera AB and BioGaia AB

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Kancera and BioGaia is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Kancera AB and BioGaia AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioGaia AB and Kancera AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kancera AB are associated (or correlated) with BioGaia AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioGaia AB has no effect on the direction of Kancera AB i.e., Kancera AB and BioGaia AB go up and down completely randomly.

Pair Corralation between Kancera AB and BioGaia AB

Assuming the 90 days trading horizon Kancera AB is expected to under-perform the BioGaia AB. In addition to that, Kancera AB is 5.46 times more volatile than BioGaia AB. It trades about -0.13 of its total potential returns per unit of risk. BioGaia AB is currently generating about -0.09 per unit of volatility. If you would invest  11,700  in BioGaia AB on September 3, 2024 and sell it today you would lose (1,000.00) from holding BioGaia AB or give up 8.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kancera AB  vs.  BioGaia AB

 Performance 
       Timeline  
Kancera AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kancera AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
BioGaia AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioGaia AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kancera AB and BioGaia AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kancera AB and BioGaia AB

The main advantage of trading using opposite Kancera AB and BioGaia AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kancera AB position performs unexpectedly, BioGaia AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioGaia AB will offset losses from the drop in BioGaia AB's long position.
The idea behind Kancera AB and BioGaia AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance